Mark G. Lebwohl, MD

home / authors / mark-g-lebwohl-md

Mark Lebwohl, MD, is dean for clinical therapeutics, and chairman emeritus at the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

Articles

Pathophysiology of Plaque Psoriasis and Targeted Therapies

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Helen Torok, MD;Jashin Wu, MD

December 16th 2021

A panel of experts review the nature of plaque psoriasis and the mechanism of action of several classes of targeted therapy.

Use of TNF Inhibitors: The Changing Treatment Paradigm

Mark G. Lebwohl, MD

August 1st 2003

Current therapies for psoriasis can be very effective and are acceptable to many patients. However, a number of drawbacks associated with these treatments may compromise their effectiveness. Patients undergoing ultraviolet B (UVB) phototherapy or psoralen plus ultraviolet A (PUVA) treatments must keep their appointments 3 times a week to maintain the effectiveness of the therapy.

<1 2 3